Company profile

Nan gaba na Sanofi

#
Rank
86
| Quantumrun Global 1000

Sanofi S.A is a French pharmaceutical company operating internationally. It was founded primarily as Sanofi Aventis when Sanofi- Synthelabo and Aventis were merged together in 2004 but its name was changed to Sanofi in 2011. The company is actively involved in researching, developing, and marketing of medicinal drugs along with the development of over-the-counter medication. As of 2013, Sanofi was the fifth largest company by prescription sales in the world. The company is engaged in seven main therapeutic areas which are central nervous system, cardiovascular, diabetes, oncology, thrombosis, internal medicine, and vaccines.

Ƙasar Gida:
Bangare:
Industry:
Pharmaceuticals
Yanar Gizo:
An kafa:
2004
Adadin ma'aikatan duniya:
110000
Adadin ma'aikatan cikin gida:
Adadin wuraren gida:
18

Lafiyar Kudi

Matsakaicin kudaden shiga na 3y:
$35413500000 EUR
Matsakaicin kashe kuɗi na 3y:
$13949000000 EUR
Kudade a ajiyar:
$10273000000 EUR
Kasar kasuwa
Kudaden shiga daga kasa
0.35
Kudaden shiga daga kasa
0.33

Ayyukan Kadari

  1. Samfura/Sabis/Dept. suna
    Kulawa na musamman
    Samfur/Sabis kudaden shiga
    5950000000
  2. Samfura/Sabis/Dept. suna
    Diabetes and cardiovascular
    Samfur/Sabis kudaden shiga
    7799000000
  3. Samfura/Sabis/Dept. suna
    Established prescription products
    Samfur/Sabis kudaden shiga
    10311000000

Kaddarorin ƙirƙira da Bututu

Zuba jari zuwa R&D:
$5082000000 EUR
Jimlar haƙƙin mallaka:
1071

Duk bayanan kamfanin da aka tattara daga rahoton shekara ta 2015 da sauran kafofin jama'a. Daidaiton wannan bayanai da kuma ƙarshe da aka samu daga gare su ya dogara da wannan bayanan da ake iya isa ga jama'a. Idan bayanan da aka jera a sama aka gano ba daidai ba ne, Quantumrun zai yi gyare-gyaren da suka dace a wannan shafin kai tsaye. 

RASHIN HANKALI

Kasancewa cikin sashin harhada magunguna yana nufin wannan kamfani zai shafi kai tsaye da kuma kai tsaye ta hanyar damammaki da kalubale da dama a cikin shekaru masu zuwa. Yayin da aka bayyana dalla-dalla a cikin rahotannin musamman na Quantumrun, ana iya taƙaita waɗannan ɓangarorin rugujewa tare da fa'idodi masu zuwa:

* Na farko, ƙarshen 2020s zai ga Silent da Boomer tsararraki sun shiga cikin manyan shekarun su. Wanda ke wakiltar kusan kashi 30-40 cikin XNUMX na al'ummar duniya, wannan haɗe-haɗen alƙaluman jama'a zai wakilci wani gagarumin nauyi a tsarin kiwon lafiya na ƙasashen da suka ci gaba.
*Duk da haka, a matsayin masu hannu da shuni da masu hannu da shuni, wannan alƙaluman jama'a za su yi ƙwaƙƙwaran ƙuri'a don ƙarin kashe kuɗin jama'a kan ayyukan kiwon lafiya don tallafa musu a cikin shekarun su.
*Tsarin tattalin arziƙin wannan ɗimbin manyan jama'a zai ƙarfafa ƙasashen da suka ci gaba da su hanzarta bin tsarin gwaji da amincewa da sabbin magungunan da za su iya inganta lafiyar jiki da tunanin tsofaffi gaba ɗaya, ta yadda za su kasance da kyau don gudanar da rayuwa masu zaman kansu a waje da ƙasar. kula da asibitoci da gidajen jinya.
*Ya zuwa farkon 2030s, jiyya iri-iri za su fito don tabarbare kuma daga baya su dawo da illar tsufa. Za a ba da waɗannan magungunan kowace shekara kuma a kan lokaci za su zama masu araha ga talakawa, wanda zai haifar da tsawon rayuwar ɗan adam da sabon iska ga masana'antar harhada magunguna.
*A shekara ta 2050, yawan al'ummar duniya zai haura biliyan tara, sama da kashi 80 cikin XNUMX nasu za su zauna a birane. Yawan adadi da yawa na yawan mutane na gaba zai haifar da ƙarin barkewar annoba na yau da kullun waɗanda ke yaduwa cikin sauri kuma suna da wahalar warkewa.
*Ayyukan da aka bazu na ilimin wucin gadi (AI) da ƙididdigar ƙididdiga a cikin masana'antar harhada magunguna za su haifar da sabbin, binciken AI-taimaka na magunguna da jiyya don warkar da kewayon yanayin likita. Wadannan masu binciken harhada magunguna na AI kuma za su haifar da sabbin magunguna da jiyya ana gano su cikin sauri fiye da yadda ake yi a halin yanzu.

MATSALAR KAMFANI

Labaran Kamfanin